Opus Genetics, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of inherited retinal diseases (IRDs). It develops OPGx ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback